INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $122,000 | +17.3% | 77,900 | 0.0% | 0.00% | – |
| Q2 2016 | $104,000 | -75.4% | 77,900 | -6.1% | 0.00% | -100.0% |
| Q1 2016 | $423,000 | -20.8% | 83,000 | +22.1% | 0.00% | 0.0% |
| Q4 2015 | $534,000 | -7.1% | 68,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $575,000 | -12.1% | 68,000 | +13.9% | 0.00% | -50.0% |
| Q2 2015 | $654,000 | -12.1% | 59,700 | +12.2% | 0.00% | 0.0% |
| Q1 2015 | $744,000 | -17.2% | 53,200 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $899,000 | +25.9% | 53,200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $714,000 | +5.3% | 53,200 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $678,000 | +20.9% | 53,200 | +12.7% | 0.00% | +50.0% |
| Q1 2014 | $561,000 | +7.3% | 47,200 | +24.5% | 0.00% | 0.0% |
| Q4 2013 | $523,000 | +2.3% | 37,900 | +29.4% | 0.00% | 0.0% |
| Q3 2013 | $511,000 | +1.4% | 29,300 | -5.5% | 0.00% | 0.0% |
| Q2 2013 | $504,000 | – | 31,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |